Influenza

Researchers say Tamiflu a waste of money

Complete data sets have prompted researchers to say Tamilflu and Relenza fail at their key reason for being: preventing flu pandemics.

Shutdown dims lights at FDA, NIH and CDC

Shutdown dims lights at FDA, NIH and CDC

By

The midnight shutdown put 800,000 government employees on leave, including those at the FDA, NIH and CDC.

Kleenex brand goes flu hunting

Kleenex brand goes flu hunting

By

The Kimberly-Clark-backed cold and flu predictor mixes Big Data, and big branding, with an individualized focus.

GSK clears another flu vaccine, but patients may not be buying

GSK clears another flu vaccine, but patients may not be buying

By

The FDA approved GlaxoSmithKline's second quadrivalent flu vaccine, but a CVS study indicates that consumers are big fans of the vaccination, as long as they aren't the ones rolling up their sleeves.

Shazam! Sanofi Pasteur strikes a chord with Fluzone audience

Shazam! Sanofi Pasteur strikes a chord with Fluzone audience

By

Sanofi Pasteur scored a pharma first this past winter by offering "Shazam" technology as a way for viewers to interact with TV commercials for its Fluzone Intradermal influenza vaccine—and to find out where they could get the new shot.

Egg-free, mercury-free flu vaccine approved

By

The FDA approved a flu vaccine that can be produced quickly, and lacks many elements that make patients skittish.

Sanofi launches Fluzone DTC with prickly-cute creative

Sanofi launches Fluzone DTC with prickly-cute creative

By

Sanofi Pasteur has launched its first consumer advertising for Fluzone Intradermal, featuring a prickly pitch-critter meant to stress the flu vaccine's extra-thin needle.

Email Newsletters